| Publications |
| Kahn
LS, Aiello J, Berdine DE, Fox CH (In press): The use
of telephonic case management to link a special-needs population
with a primary care physician. JABFM. |
| |
| McIntyre
RS, Rasgon NL, Kemp DE, Nguyen HT, Law CW, Taylor V, Woldeyohannes
HO, Alsuwaidan MT, Soczynska JK, Kim B, Lourenco MT, Kahn
LS, Goldstein BI. Metabolic Syndrome and Major Depressive
Disorder: Co-occurrence and Pathophysiologic Overlap. Current
Diabetes Reports 2009;9:51-59. |
| |
| Kahn
LS, Fox CH, Mcintyre RS, Tumiel-Berhalter L, Berdine
DE, Lyle H. Assessing the Prevalence of Depression Among Individuals
with Diabetes in a Medicaid Managed-care Program. Int'l J Psychiatry
in Medicine 2008;38(1):13-29. |
| |
| Griswold
KS, Aronoff H, Kernan JB, Kahn LS. Adolescent
Substance Use and Abuse: Recognition and Management. American
Family Physician 2008; 77(3):331-336. |
| |
| Fox
CH, Voleti V, Kahn LS, Murray B, Vassalotti
J. A Quick Guide to Evidence-Based Chronic Kidney Disease Care
for the Primary Care Physician. Post Graduate Medicine 2008;
120(2):E01-6. |
| |
| Fox
CH, Swanson AR, Kahn LS, Glaser K. Improving
Chronic Kidney Disease Care in Primary Care Practices: An Upstate
New York Practice Based Research Network (UNYNET) Study. Journal
of the American Board of Family Practice 2008;21(6):522-530. |
| |
| Fox
C, Kahn LS. The Importance of Patient Education
in the Treatment of Chronic Kidney Disease. Kidney International
2008 Nov;74(9):1114-5. |
| |
| Fox
C, Kahn LS. The importance of patient education
in the treatment of chronic kidney disease. Kidney International
2008 Nov;74(9):1114-5. |
| |
| Fox
CH, Swanson BA, Kahn LS, Glaser K, Murray B:
Improving chronic kidney disease care in primary care practices:
a UNYNET study JABFM. 21 (6): 522-530 |
| |
| Fox
CH, Voleti V, Kahn LS, Murray B, Vassalotti
J (2008): A quick guide to evidence-based chronic kidney disease
care for the primary care physician. Postgrad Med 120:E01-06. |
| |
| Kahn
LS., Cadzow, R., Tumiel-Berhalter, L, Watkins, B, Taylor,
J, Leonard, K (2007) Providing health insurance to small-businesses
through a subsidy demonstration program, Social Work in Public
Health 23(1): 143-155. |
| |
|
Griswold KS, Kernan JB, Aronoff H, Kahn LS
(2008) Adolescent substance use: recognition and management.
American Family Physician 77 (3): 331-336. |
| |
| Fox
CH, Kahn L, Robinson A. Practice Facilitators
and Practice-Based Research Networks. Journal of the American
Board of Family Practice. |
| |
| Kahn
LS, Tumiel-Berhalter L, Cadzow R, Watkins R, Leonard
KM, Taylor JS (2007): The impacts of subsidized health insurance
on employees' use of preventive health services. Eval Health
Prof 30:22-34. |
| |
| Halbreich
U, Kahn LS. Atypical Depression and Anxious
Depression in Women: Are They Gender-Preferred Phenotypes? Journal
of Affective Disorders 2007; 102:245-258. |
| |
| Cramer
JS, Sibley RF, Bartlett DP, Kahn LS, Loffredo
L. An Adaptation of the Diabetes Prevention Program for Use
with High Risk, Minority Patients with Type 2 Diabetes. The
Diabetes Educator 2007; 33:503. |
| |
| Kahn
LS, Fox CH, Berdine DE, Krause-Kelly J, Raghu V. A
Physician Self-Assessment Tool for Quality Improvement. Journal
for Healthcare Quality 2007 March/ April; 29(2):38-43. |
| |
| Kahn
LS, Fox CH, Olawaiye A, Servoss TJ, McLean-Plunkett
E (2007). Facilitating Quality Improvement in Physician Management
of Co-Morbid Chronic Disease in an Urban Minority Practice Journal
of the National Medical Association 99(4): 377-383. |
| |
| Kahn
LS, Halbreich U, Bloom MS, Bidani R, Rich E, Hershey CO.
Screening for Mental Illness in Primary Care Clinics. Int J
Psychiatry Med. 34(4) 345-362 |
| |
| Halbreich
U, Kahn LS (In press): Mood and Behavioral Effects of
Oral Contraceptives. Mental Fitness |
| |
| Kahn
L, Halbreich U (2005): The effect of estrogens on depression.
In Bergemann N, Riecher-Rossler A (eds), Estrogen effects in
psychiatric disorders. New York: Springer Wien, pp 145-173. |
| |
| Halbreich
U, Kahn LS (2004): Gender and pathophysiology of affective
disorders: rationale for gender-specific treatments. In den
Boer H, ter Horst GJ, George M (eds), Current and future directions
in psychopharmacology. Amsterdam: Benecke. |
| |
| Halbreich
U, Kahn LS (2003): Treatment of premenstrual dysphoric
disorder with luteal phase dosing of sertraline. Expert Opin
Pharmacother 4:2065-78. |
| |
| Halbreich
U, Kahn LS (2003): Hyperprolactinemia and schizophrenia:
mechanisms and clinical aspects. J Psychiatric Practice 9(3):
341-353. |
| |
Kahn
LS, Halbreich U (2003): Understanding Premenstrual Syndromes.
Primary Psychiatry 10:41-45.
|
| |
| Halbreich
U, Kahn LS (2003): Hormonal Aspects of Schizophrenias:
An Overview. Psychoneuroendocrinology 28, Supp2:1-16. |
| |
|
Halbreich U, Kinon BJ, Gilmore JA, Kahn LS (2003): Elevated
prolactin levels in patients with schizophrenia: mechanisms
and related adverse effects. Psychoneuroendocrinology 28 Suppl
1:53-67. |
| |
| Halbreich
U, Borenstein J, Pearlstein T, Kahn LS (2003): The prevalence,
impairment, impact, and burden of premenstrual dysphoric disorder
(PMS/PMDD). Psychoneuroendocrinology 28 Suppl 3:1-23. |
| |
| Halbreich
U, Wamback S, Kahn LS (2003): Clinical psychotropic effects
of gonadal hormone medications in women. In Wolkowitz O, Rothschild
A (eds), Psychoneuroendocrinology: The scientific basis of clinical
practice. Washington D.C.: American Psychiatric Press, Inc.,
pp 303-330. |
| |
| Halbreich
U, Kahn LS (2003): Depression in Menopausal Women. In
Genazzani AR (ed), Hormone Replacement Therapy and the Brain.
London: Parthenon Publishers, pp 150-160. |
| |
| Mitwally
MF, Kahn LS, Halbreich U (2002): Pharmacological Management
of Premenstrual Syndromes (PMS) and Premenstrual Dysphoric Disorder:
Current Treatment Practices. Expert Opin Pharmacother 3:1577-1590. |
| |
| Halbreich
U, Kahn LS (2002): Estrogens, Age-related Deterioration
in Cognition, and Dementia. In Gaszner P, Halbreich U (eds),
Women's Mental Health -- An Eastern European Perspective. Budapest,
Hungary: World Psychiatric Association, Section on Interdisciplinary
Collaboration. Pp. 81-93. |
| |
| Halbreich
U, Kahn LS (2001): Role of estrogen in the aetiology
and treatment of mood disorders CNS Drugs 15(10): 745-817. |
| |
|
Kahn LS. Halbreich U: (2001) Oral contraceptives and
mood. Expert Opin Pharmacother 2: 1367-1382. |
| |
| Halbreich
U, Kahn LS (2001): Are women with premenstrual dysphoric
disorder prone to osteoporosis? Psychosom Med . 63:361-364. |
| |
| Halbreich
U, Kahn LS (2000): Selective oestrogen receptor modulators--current
and future brain and behaviour applications. Expert Opin Pharmacother
1:1385-98. |
| |
Halbreich
U, Yonkers KA, Kahn LS (2000): Gender differences in
dysthymia. In Steiner M, Yonkers KA, Erickson E (eds), Mood
disorders in women. London: Martin Dunitz, pp 107-118.
|
| |
| Kahn
LS, Halbreich U (1999): Menopause and psychopharmacology:
signs, symptoms, and treatment. In Crosignani PG, Kenemans K,
Wenger NK, Jackson AS (eds), Women's health and menopause: risk
reduction strategies -- improved quality of health. Boston:
Kluwer Academic Publishers, pp 131-136. |
| |
| Kahn
LS (1994): The cross cultural study of education. In Husen
T, Postlethwaite N (eds), The International Encyclopedia of
Education, Vol 2nd edition. London: Pergamon Press, pp 1208-1213. |
| |
| Kahn
LS (1986): The impact of cultural identity on Quebecois
education. Quebec Studies Summer 1986. |
| |
| Kahn
LS, Ogbu J (1984): Review of Enculturation and Education
in Shanti Nagar by Ruth S. Freed and Stanley A. Freed. Anthropology
and Education Quarterly 15:121-124. |
